Search results for " Cochrane"

showing 3 items of 3 documents

Antifungal Stewardship in Light of the Updated Evidence on Untargeted Antifungal Treatment in Critically Ill Patients

2016

Microbiology (medical)Antifungalmedicine.medical_specialtybusiness.industrymedicine.drug_classCritically illAntifungal TreatmentEarly InstitutionCochrane Systematic ReviewFungal InfectionSurgeryInfectious DiseasesMedical microbiologymedicineInvasive Fungal InfectionAntifungal Treatment; Cochrane Systematic Review; Early Institution; Fungal Infection; Invasive Fungal InfectionStewardshipIntensive care medicinebusiness
researchProduct

Assessing the quality of studies in meta-research: Review/guidelines on the most important quality assessment tools

2020

Systematic reviews and meta-analyses pool data from individual studies to generate a higher level of evidence to be evaluated by guidelines. These reviews ultimately guide clinicians and stakeholders in health-related decisions. However, the informativeness and quality of evidence synthesis inherently depend on the quality of what has been pooled into meta-research projects. Moreover, beyond the quality of included individual studies, only a methodologically correct process, in relation to systematic reviews and meta-analyses themselves, can produce a reliable and valid evidence synthesis. Hence, quality of meta-research projects also affects evidence synthesis reliability. In this overview…

Statistics and ProbabilityCONSORTmedia_common.quotation_subjectPRISMAmeta-researchStrengthening the reporting of observational studies in epidemiology01 natural sciencesAMSTAR-PLUS; AMSTAR2; CONSORT; Cochrane; NOS; PRISMA; STROBE; meta-analysis; meta-research; quality010104 statistics & probability03 medical and health sciences0302 clinical medicineAMSTAR-PLUSBiasSTROBEMedicineHumansPharmacology (medical)Quality (business)AMSTAR2 AMSTAR-PLUS Cochrane CONSORT meta-analysis meta-research NOSPRISMA quality STROBE030212 general & internal medicine0101 mathematicsmedia_commonPharmacologyReview/guidelines on the most important quality assessment tools- PHARMACEUTICAL STATISTICS 2020 [Luchini C. Veronese N. Nottegar A. Shin J. I. Gentile G. Granziol U. SOYSAL P. Alexinschi O. Smith L. Solmi M. -Assessing the quality of studies in meta-research]business.industryConsolidated Standards of Reporting TrialsReproducibility of ResultsEvidence-based medicineNOSJadad scaleAMSTAR2meta-analysisSystematic reviewCochraneRisk analysis (engineering)AMSTAR-PLUS; AMSTAR2; Cochrane; CONSORT; meta-analysis; meta-research; NOS; PRISMA; quality; STROBEqualityResearch DesignMeta-analysisObservational studybusiness
researchProduct

The laparoscopic approach to Acute Mesenteric Ischemia is today unclear and less debated (AMI). There are in fact no clinical evidences on this parti…

2016

The laparoscopic approach to Acute Mesenteric Ischemia is today unclear and less debated (AMI). There are in fact no clinical evidences on this particular focus and only few articles can be found in several databases (pubmed, cochrane library, etc.), and the problem concerns both diagnostic and therapeutic utilization of the procedure. These considerations were already taken into account in 2012 EAES guidelines where the Grade of Recommendation (GoR) of laparoscopy in AMI was low in both diagnostic and therapeutic aspects. According to the new Oxford Classification [1], the use of laparoscopy in patients with suspicious or diagnosed AMI presents a weak GoR.

The laparoscopic approach to Acute Mesenteric Ischemia is today unclear and less debated (AMI). There are in fact no clinical evidences on this particular focus and only few articles can be found in several databases (pubmed cochrane library etc.) and the problem concerns both diagnostic and therapeutic utilization of the procedure. These considerations were already taken into account in 2012 EAES guidelines where the Grade of Recommendation (GoR) of laparoscopy in AMI was low in both diagnostic and therapeutic aspects. According to the new Oxford Classification [1] the use of laparoscopy in patients with suspicious or diagnosed AMI presents a weak GoR.
researchProduct